Hodgkin Lymphoma: Chemo Regimens Need Not Include BleomycinAn abstract is unavailable.FromerMargot J
HSCT for low-grade non-Hodgkin's lymphoma in adults low bulk disease until clear indications for initiation of treatment are seen, except for those patients enrolled in clinical trials assessing the impact of early therapy. This approach is based upon the demonstration of no survival adva... J...
The clinical application of rituximab (chimeric mouse anti-human CD20 mAb, Rituxan, IDEC-C2B8), alone and/or combined with chemotherapy, has significantly ameliorated the treatment outcome of patients with relapsed and refractory low-grade or follicular non-Hodgkin's lymphoma (NHL). The exact in ...
An abstract is unavailable.doi:10.1097/01.COT.0000290061.31781.36SusmanEdOncology Times
EP-1053: Efficacy and toxicity of chemo-radiotherapy in Hodgkin铆s lymphoma: A single institution experienceDi BiaseConsonCellaPuglesePicardi
Tasheema Prince
Mehreen Dharsee
(1984). Treatment of refractory non-Hodgkin's lymphoma with intensive chemoradiotherapy and autologous bone marrow transplant. Proc. Am. SOCC. lin. Oncol.,3,239.Braine HG, Kaizer H, Yeager AM, Stuart R, Burns WH, Sara1 R, Sensenbrenner LL, Santos G W Treatment of refractory non-Hodgkin...
Cabanillas, FMcLaughlin, PHagemeister, FRodriguez, M ARomaguera, J EYounes, ASarris, A HPro, BDang, NSamaniego, F
Hypothyroidism (HT) is a frequent late side effect of Hodgkin's lymphoma (HL) therapy. The purpose of this study is to determine dose–volume constraints that correlate with functional impairment of the thyroid gland in HL patients treated with three-dimensional radiotherapy. A total of 61 ...